Evidence map›Paper›PMID 41314147›Full record

Trial reportEBioMedicine2025

High-intensity interval training outperforms moderate exercise to improve aerobic capacity in patients with recent-onset idiopathic inflammatory myopathies: a multicentre randomised controlled trial.

Kristofer M Andreasson, Cecilia Leijding, Maryam Dastmalchi, Antonella Notarnicola, Stefano Gastaldello, Takashi Yamada, Heléne Sandlund, Dag Leonard, Håkan Westerblad, Ingrid E Lundberg and 2 more

Abstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in EBioMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kristofer M AndreassonKarolinska University Hospital, Theme Women's Health and Allied Health Professionals, Medical Unit Allied Health Professionals, Stockholm, Sweden; Division of Rheumatology, Department of Medicine, Karolinska Institutet, Solna, Stockholm, Sweden. Electronic address: kristofer.andreasson@ki.se.
Cecilia LeijdingDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Maryam DastmalchiDepartment of Gastro, Dermatology and Rheumatology, Karolinska University Hospital, Theme Inflammation and Aging, Stockholm, Sweden.
Antonella NotarnicolaDivision of Rheumatology, Department of Medicine, Karolinska Institutet, Solna, Stockholm, Sweden; Department of Gastro, Dermatology and Rheumatology, Karolinska University Hospital, Theme Inflammation and Aging, Stockholm, Sweden.
Stefano GastaldelloDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Takashi YamadaGraduate School of Biomedical and Health Sciences, Hiroshima University.
Heléne SandlundDepartment of Gastro, Dermatology and Rheumatology, Karolinska University Hospital, Theme Inflammation and Aging, Stockholm, Sweden.
Dag LeonardDepartment of Medical Sciences, Section of Rheumatology, Uppsala University, Uppsala, Sweden.
Håkan WesterbladDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Ingrid E LundbergDivision of Rheumatology, Department of Medicine, Karolinska Institutet, Solna, Stockholm, Sweden; Department of Gastro, Dermatology and Rheumatology, Karolinska University Hospital, Theme Inflammation and Aging, Stockholm, Sweden.
Daniel C AnderssonDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden; Karolinska University Hospital, Theme Heart, Vascular and Neuro, Cardiology Unit, Stockholm, Sweden.
Helene AlexandersonKarolinska University Hospital, Theme Women's Health and Allied Health Professionals, Medical Unit Allied Health Professionals, Stockholm, Sweden; Division of Rheumatology, Department of Medicine, Karolinska Institutet, Solna, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo investigate efficacy, safety, and tolerance of high-intensity interval training (HIIT) vs. clinical standard low-moderate intensity home-based exercise (CON) to improve aerobic capacity, muscle endurance, and mitochondrial function in patients with recent onset, idiopathic inflammatory myopathies (IIM).

methodsTwenty-three patients with recent onset IIM were randomised into HIIT or CON groups. Both groups underwent 12 weeks of exercise training. The HIIT did 3 sessions/week, always supervised during the first three weeks. Then, training was supervised 1-3 session per week based on an individual assessment of the participants' preference and ability to perform HIIT in the clinic. The CON received one supervised session and then exercised five days per week at home, following clinical standard. Primary outcome was maximal exercise test (VO

findingsHIIT resulted in a 16% increase in VO

interpretationHIIT is an effective and safe exercise intervention to improve aerobic fitness, muscle endurance, and mitochondrial function in patients with recent onset IIM. This approach should be considered an adjuvant treatment in managing IIM, potentially health-enhancing for these patients.

fundingSwedish Research Council, the Swedish Rheumatism Association, Stockholm County Research Grant (ALF), King Gustaf V 80-year Foundation, the Swedish Heart and Lung Foundation, Promobilia Foundation, and Stig Thune Foundation.

Indexed as

ExerciseExercise TherapyExercise ToleranceHigh-Intensity Interval TrainingMyositisAdultFemaleHumansMaleMiddle AgedMuscle, SkeletalMuscle StrengthOxygen ConsumptionTreatment OutcomeAerobic capacityExerciseHigh-intensity interval trainingIdiopathic inflammatory myopathies (IIM)MitochondriaMyositis

Identifiers

PMID41314147
PMCPMC12703967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.